Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoids to reduce atrioventricular block and pacemaker implantation after TAVI
2022-003861-39Phase 2Active
- Sponsor
- JUAN MIGUEL RUIZ NODAR
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methylprednisolone and prednisone in aortic stenosis (AS), atrioventricular block and conduction defect, sponsored by JUAN MIGUEL RUIZ NODAR. Primary endpoint: Incidence of conduction disturbances and need for permanent pacemaker implantation after TAVI. Started Jan 2023; status: active.
02
Drugs
methylprednisoloneprednisone
03
Conditions
aortic stenosis (AS)atrioventricular blockconduction defect
Beyond the preview
Go deeper on 2022-003861-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003861-39.